Cargando…
SAT-689 Amantadine Induced Severe Hypoglycemia in a Patient With Type 1 Diabetes and Multiple Sclerosis
Introduction: Amantadine is one of the few options commonly used to treat fatigue associated with multiple sclerosis. However, in a previous trial investigating the effect of amantadine on oral glucose tolerance test results, amantadine caused a reduction in plasma glucose and glucagon levels while...
Autores principales: | Mishriky, Basem M, Cummings, PharmD, Doyle M, Powell, James R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208154/ http://dx.doi.org/10.1210/jendso/bvaa046.201 |
Ejemplares similares
-
MON-689 Diabetes Mellitus---Hypoglycemic Response---Empyema
por: Chen, Yaning
Publicado: (2020) -
SAT-679 Autoimmune Hypoglycemia: A Treatment Challenge
por: Santana, Nadyeschka Angelique Rivera, et al.
Publicado: (2020) -
SAT-LB110 Sulfonylurea-Induced Hypoglycemia: To Use Octreotide or Not
por: Romeu, Jose, et al.
Publicado: (2020) -
SUN-689 Treatment of Hepatitis C Has Time-Dependent Relationship with Type 2 Diabetes Progress
por: Liu, Luna, et al.
Publicado: (2020) -
OR30-02 Efficacy and Safety Comparison Between U100 Regular Human Insulin and U100 Rapid Acting Insulin When Delivered by a 24 Hour Wearable Insulin Delivery Device in Type 2 Diabetes
por: Mora, Pablo, et al.
Publicado: (2020)